Merck To Support Zocor Into 2006 Based On Strong Formulary Position
This article was originally published in The Pink Sheet Daily
Executive Summary
Position of Zocor, Vytorin on Express Scripts' preferred formulary is a win-win for Merck, CEO Clark states during Q3 call.
You may also be interested in...
Part D Formulary Negotiations Take “Portfolio Approach” For AstraZeneca
AstraZeneca has adopted a "portfolio approach" in its negotiations with prescription drug plans to gain strong Medicare Part D formulary positions, Chief Financial Officer Jonathan Symonds said
Part D Formulary Negotiations Take “Portfolio Approach” For AstraZeneca
AstraZeneca has adopted a "portfolio approach" in its negotiations with prescription drug plans to gain strong Medicare Part D formulary positions, Chief Financial Officer Jonathan Symonds said
Pfizer Will Work With Express Scripts’ Customers To Provide Lipitor
Pfizer said it will work directly with Express Scripts' health plan customers to provide Lipitor (atorvastatin) after the pharmacy benefit manager dropped the cholesterol medication from its preferred formulary